[Newborn intestinal colonization by multidrug resistant enterobacteria in a neonatal unit]

L A Vieira1, E A Castro, J L Duarte

  • 1Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, RJ, Brazil.

Jornal De Pediatria
|December 20, 2003
PubMed

Insights

Multidrug-resistant enterobacteria strains (MDRES) colonized nearly half of newborns studied. Risk factors like antibiotic use and artificial feeding were linked to this colonization, increasing infection risk.

Area of Science:

  • Microbiology
  • Neonatal Health
  • Infectious Diseases

Background:

  • Neonatal intestinal colonization by multidrug-resistant enterobacteria strains (MDRES) is a growing concern.
  • Understanding colonization risk factors is crucial for preventing nosocomial infections in newborns.

Purpose of the Study:

  • To evaluate the occurrence of intestinal colonization by MDRES in newborns during their hospital stay.
  • To determine the relationship between MDRES isolation and potential colonization risk factors.

Main Methods:

  • A sequential inclusion study of 30 newborns in a tertiary care hospital neonatal unit.
  • Selective culture media (gentamicin and potassium tellurite) used for fecal sample analysis.
  • Biochemical identification, antimicrobial susceptibility testing, and plasmid transfer assays for isolated strains.

Main Results:

  • 56 distinct MDRES were isolated from 14 out of 30 newborns (46.7%).
  • Klebsiella pneumoniae was the most prevalent species (68%).
  • MDRES isolation showed a statistical association with antimicrobial use, low birth weight, prolonged hospitalization, and artificial milk feeding (p<0.02).

Conclusions:

  • Selective culture media effectively detected high-frequency newborn colonization by MDRES.
  • Established infection risk factors are associated with MDRES intestinal colonization in neonates.
  • Reinforcing infection control measures is vital to prevent nosocomial infections originating from intestinal colonization.

Related Concept Videos

Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Microbiota of the Large Intestine01:27

Microbiota of the Large Intestine

The large intestine hosts the most densely populated microbial ecosystem in the human body. This complex community primarily consists of anaerobic bacteria, with Bacillota (formerly Firmicutes) and Bacteroidota (formerly Bacteroidetes) as the predominant groups. The distribution of these microbes varies along different sections of the large intestine, influenced by local environmental factors such as oxygen availability and nutrient composition.The cecum, located at the beginning of the large...